DexCom, Inc. (DXCM)
85.36
-0.87
(-1.01%)
USD |
NASDAQ |
Oct 02, 16:00
85.36
0.00 (0.00%)
After-Hours: 20:00
DexCom Gross Profit Margin (Quarterly) : 63.44% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.44% |
| March 31, 2026 | 66.19% |
| December 31, 2025 | 62.93% |
| September 30, 2025 | 61.80% |
| June 30, 2025 | 59.53% |
| March 31, 2025 | 56.85% |
| December 31, 2024 | 58.90% |
| September 30, 2024 | 59.73% |
| June 30, 2024 | 62.40% |
| March 31, 2024 | 61.01% |
| December 31, 2023 | 63.69% |
| September 30, 2023 | 63.75% |
| June 30, 2023 | 62.52% |
| March 31, 2023 | 62.14% |
| December 31, 2022 | 66.18% |
| September 30, 2022 | 59.12% |
| June 30, 2022 | 64.29% |
| March 31, 2022 | 63.31% |
| December 31, 2021 | 67.49% |
| September 30, 2021 | 64.81% |
| June 30, 2021 | 70.00% |
| March 31, 2021 | 68.10% |
| December 31, 2020 | 70.15% |
| September 30, 2020 | 67.96% |
| June 30, 2020 | 62.88% |
| Date | Value |
|---|---|
| March 31, 2020 | 63.32% |
| December 31, 2019 | 66.83% |
| September 30, 2019 | 62.30% |
| June 30, 2019 | 61.39% |
| March 31, 2019 | 60.18% |
| December 31, 2018 | 65.92% |
| September 30, 2018 | 64.68% |
| June 30, 2018 | 64.74% |
| March 31, 2018 | 66.92% |
| December 31, 2017 | 69.46% |
| September 30, 2017 | 71.72% |
| June 30, 2017 | 70.87% |
| March 31, 2017 | 69.64% |
| December 31, 2016 | 68.17% |
| September 30, 2016 | 71.53% |
| June 30, 2016 | 67.59% |
| March 31, 2016 | 69.97% |
| December 31, 2015 | 69.72% |
| September 30, 2015 | 71.01% |
| June 30, 2015 | 70.82% |
| March 31, 2015 | 63.87% |
| December 31, 2014 | 70.46% |
| September 30, 2014 | 68.41% |
| June 30, 2014 | 67.86% |
| March 31, 2014 | 63.27% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| Insulet Corp. | 72.56% |
| Baxter International, Inc. | 33.55% |
| Stryker Corp. | 66.14% |
| Becton, Dickinson & Co. | 46.46% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.69% |
| Return on Assets | 14.59% |
| Return on Invested Capital | 21.78% |
| Profit Margin (Quarterly) | 19.04% |
| Operating Margin (Quarterly) | 24.33% |
| Return on Net Operating Assets | 27.51% |